12/10/2010 15:00:00

Alion Awarded EPA Contract Valued at up to $72 Million to Conduct Research on Human Pollutant Exposures

Alion Science and Technology, an employee-owned technology solutions

company, was awarded a five-year task-order from the Environmental

Protection Agency (EPA), worth a maximum of $72 million, to continue its

work providing research support to assess exposure to atmospheric

pollutants and other materials that have the potential to cause adverse

human health effects.

Alion supports EPA’s Office of Research and Development by assisting

with the conduct of research that characterizes human pollutant

exposures across a broad spectrum. Our subcontractor RTI International

is a key partner in this effort. Results will be applied to practical

efforts related to air quality measurement, pollution control and

homeland security.

“We support the continuing improvement in our understanding of how

people become exposed to air pollutants,” explained Chris Amos, Alion

Senior Vice President and Manager of the company’s Technology Solutions

Group. “Alion has a long history with EPA, dating back to 1973, in

conducting atmospheric sciences and environmental methods development

research, with an increased emphasis on studying human exposure.

Ultimately, the research we are conducting now may help prevent negative

health effects from pollutants.”

Under the contract, Alion will develop and support human exposure models

and support research in aerosol and human exposure studies. Pollutants

and other compounds will be sampled and analyzed in air, water, food,

dust, soil and biological media, and tracked through inhalation, dermal

exposure and ingestion.

Other subcontractors on the five-year contract include The McConnell

Group and Alpha-Gamma Technologies.

The mission of EPA is to protect human health and the environment. EPA's

purpose is to ensure that all Americans are protected from significant

risks to human health and the environment where they live, learn and

work.

About Alion Science and Technology

Alion Science and Technology is an employee-owned technology solutions

company delivering technical expertise and operational support to the

Department of Defense, civilian government agencies and commercial

customers. Building on almost 75 years of R&D and engineering expertise,

Alion brings innovation and insight to multiple business areas: naval

architecture & marine engineering; defense operations; modeling &

simulation; technology integration; information technology & wireless

communications; and energy and environmental sciences. Based in McLean,

Virginia, Alion employee-owners are located at major offices, customer

sites and laboratories worldwide. For more information, call

877.771.6252 or visit Alion online at www.alionscience.com.

This press release contains information about management’s view of

Alion’s future expectations, plans and prospects that constitute

forward-looking statements for purposes of the safe harbor provisions

under The Private Securities Litigation Reform Act of 1995. Actual

results may differ materially from those indicated by these

forward-looking statements as a result of a variety of risk factors and

uncertainties discussed in documents periodically filed by Alion with

the SEC.

Due to such uncertainties and risks, readers are

cautioned not to place undue reliance on such forward-looking

statements, which speak only as of the date hereof.

Alion Science and Technology

Peter J. Jacobs, 703-269-3473

pjacobs@alionscience.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Dec
VELO
Gennemgang og analyse af Veloxis' søgsmålJeg har brugt min aften på at "hygge" mig med Veloxis netop..
65
20 Dec
 
Det er meget velbeskrevet i talrige bøger og artikler, at tilstandene i store dele af verden udenfor..
42
14 Dec
GEN
Genmab kom sent fredag med en fondbørsmeddelse om en milestone på $3 milloner vedrørende deres DuoBo..
30
18 Dec
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
29
18 Dec
GEN
Med FDA´s godkendelse af Amgens (Micromet) godkendelse af Blincyto (blinatumomab), fik vi for alvor ..
27
18 Dec
PNDORA
Nu har jeg købt og solgt aktier i 8 år og var os her på debatten for 4-5 år siden men har glemt mit ..
24
14 Dec
VWS
Lomborg ved udmærket godt han er på gyngende grund, i mange af hans påstande.   Den værste er, når h..
17
18 Dec
 
  Jeg er gratist, jeg læser med på EI uden at skrive. Det er sjældent, man kan få gratis lunch; men ..
13
14 Dec
MAERSK-B
Husk nu at en produktions nedgang på små 500000 tønder om dagen kan få prisen til at stige markant m..
12
15 Dec
GEN
Genmab har afholdt bestyrelsesmøde og valgt at give bestyrelse, direktion og ledende medarbejdere op..
11

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Neste Oil to revise its full-year 2014 guidance
2
Acquisition of U.S. watering brands Gilmour and Nelson has been completed
3
NASDAQ Nordic Equity & Index Derivatives Markets
4
NASDAQ Nordic Equity & Index Derivatives Markets

Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 December 2014 06:50:51
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20141211.1 - EUROWEB2 - 2014-12-21 07:50:51 - 2014-12-21 06:50:51 - 1000 - Website: OKAY